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Introduction
Conventional treatment of fever by synthetic drugs may 
cause side-effects and may not be universally affordable. 
Therefore, use of herbal medicines is more attractive 
in treatment because it is generally affordable, closely 
conforms to patient’s ideology, arguably more tolerable 
than synthetic drugs and satisfies desire for more 
personalized healthcare (1).
Aqueous extracts of Ximenia americana have been 
traditionally used in fever management. However, there is 
no documented evidence on activities of organic extracts 
of X. americana. This study scientifically evaluated and 
provided preliminary information on organic leaf and 
stem bark extracts of X. americana as an alternative, 
arguably affordable and with less side effects in fever 
management. The study also tries to reveal the gaps for 
further research.
Fever is defined as elevation of the body temperature 
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Implication for health policy/practice/research/medical education:
This study confirms the antipyretic potential of the leaf and stem bark of DCM-MeOH extracts of X. americana in experimental 
animals. Therefore, the DCM-MeOH leaf and stem bark extracts of X. americana might prove useful in managing pyrexia and 
thus serve as an alternative treatment bioresource.
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Introduction: In most parts of Africa, Ximenia americana is used in folklore to treat various 
disorders such as oedema, pain, fever, helminthiasis, diarrhoea, burns among other diseases. This 
study tested the antipyretic activities of dichloromethane-methanolic (DCM-MeOH) stem bark 
and leaf extracts of X. americana in rats. Qualitative phytochemical screening was also done to 
evaluate the presence of alkaloids, f lavonoids, steroids, saponins, cardiac glycosides, phenolics and 
terpenoids in the extract. 
Methods: The plant materials were collected from Mbeere North sub-county, Embu county, Kenya. 
Methanol and dichloromethane in the ratio of 1:1 was used to extract the active compounds. Two 
to three months old male Wister rats were employed for the antipyretic studies. Animals were 
divided into six groups of five rats each: normal, negative, reference and three experimental groups 
(50, 100 and 150 mg/kg body weight). Pyrexia was induced experimentally using turpentine. 
The experimental groups were treated with predetermined dose quantities of prepared extracts. 
Aspirin was used as the reference drug. Data were analyzed using one-way analysis of variance 
(ANOVA). 
Results: The extracts from the leaves lowered rectal temperature by 0.45% to 2.11% while the 
stem bark extracts lowered rectal temperature in the range of 0.71% to 2.13%. Aspirin lowered the 
rectal temperature in the range of 0.74% and 1.67%. Qualitative phytochemical screening showed 
presence of alkaloids, f lavonoids, saponins, cardiac glycosides, phenolics and terpenoids in the 
extract. 
Conclusion: DCM-MeOH leaf and stem bark extracts of X. americana is effective in management 
of fever and therefore it can be explored as a possible bio-resource in the development of herbal 
antipyretic medicines.
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above the normal range due to an increase in temperature 
regulatory set-point (2). It is caused by prostaglandin E2 
which is synthesized from arachidonic acid by the action of 
cyclooxygenase (COX) enzymes (3). Fever is part of acute-
phase response to inflammatory response or an infection 
(4). it is induced by a class of inflammatory mediators 
known as cytokines. Examples of such cytokines are 
interleukin-1, interleukin-6 and tumor necrosis factor-α 
(TNFα) (5). 
Turpentine induces fever in laboratory animals by 
increasing prostaglandins synthesis (6). This fever is 
better tolerated by animals than that induced by other 
exogenous pyrogens. Hence, turpentine was selected to be 
used in current study as a pyrogen (7). 
Since pyrexia is a product of prostaglandins of the E 
series activities (8), blockade of prostaglandin E2 synthesis 
helps alleviate fever. The synthesis of prostaglandin 
E2 occurs in three steps: synthesis of arachidonic acid 
from cell membrane phospholipids, a process mediated 
by phospholipase A2; synthesis of prostaglandin H2 
from arachidonic acid, a step catalyzed by COX and 
the last step is isomerization of prostaglandin H2 into 
prostaglandin E2 by the action of terminal prostaglandin 
E synthase (9). COX enzymes exist in two isoforms. The 
first is constitutive isoform, referred to as COX-1. COX-1 
has clear physiologic functions. The second is inducible 
isoform, referred to as COX-2 (10). The non-steroidal anti-
inflammatory drugs exert anti-inflammatory activities 
through COX-2 inhibition. The inhibition of COX-1 
causes side-effects, such as erosion of gastric mucosa (10). 
The side effects associated with such synthetic drugs can 
be avoided by use of reliable naturally occurring agents 
which are effective with minimal side effects (11).
Medicinal plants are either directly or indirectly used. 
They are directly used as home remedies or indirectly in 
development of conventional drugs (12). Traditionally, X. 
americana is used in the treatment of a variety of disorders 
such as: pain, fever and inflammation (13,14), treatment 
of helminthiasis (15), diarrhea, wounds (16), headaches, 
skin ulcers, kidney and heart problems (17). Mbeere 
community (a community living upper eastern Kenya) use 
pounded stem bark and raw leaves of X. americana to treat 
stomach discomforts, fever, oedema, and pain. Despite the 
broad folklore use of X. americana, there is no scientific 
evaluation of its organic extracts. The current study was 
designed against this background to specifically bioscreen 
dichloromethane-methanolic (DCM-MeOH) stem bark 
and leaf extracts of X. americana for antipyretic potential.
Materials and Methods
Collection and preparation of plant samples
Leaves and stem barks of X. americana were collected 
with the help of local traditional herbalists from Mbeere-
North in Embu county, Kenya. The plant materials were 
properly sorted, cleaned and packed in polythene bags 
and transported to Biochemistry and Biotechnology 
laboratories of Kenyatta University for further processing. 
The botanical authentication of the materials was done by a 
qualified taxonomist and the voucher specimen deposited 
in Kenyatta University Herbarium. The plant materials 
chopped, completely air dried at room temperature 
followed by grinding into fine homogenous powder with 
an electric mill and then sieved through mesh sieve.
Extraction 
For each sample, 200 g of the powder was soaked in 
cold 1:1 mixture of methanol and DCM and stirred for 
six hours to extract the active compounds. This was 
followed by successive filtering of the extracts and the 
filtrate concentrated under reduced pressure and vacuum 
using rotary evaporator (Buchii R110). The concentrate 
was stored in airtight containers at -4°C before use in the 
bioassay studies (18).
Laboratory animals
Male Wister rats, Rattus norvegicus, aged 2-3 months 
and weighing between 140-180 g were used (19). The 
animals were acquired and bred at the animal breeding 
and experimentation laboratory in Kenyatta University, 
Department of Biochemistry and Biotechnology. The 
animals were kept in standard cages, under the conditions 
of a standard laboratory (ambient temperature of 25°C 
and 12-hour light followed by 12 hour dark cycle) 
throughout the experiments. The feeding was on standard 
pellets for rodents and water was supplied ad libitum 
(20). Throughout the study, all ethical guidelines and 
procedures on animal handling were followed (21).
Determination of antipyretic activities
The experimental animals (30 male Wistar albino rats) 
were divided into 6 groups of five rats each and treated as 
shown in the table (Table 1). 
The digital thermometer was calibrated against mercury 
thermometer. The rectal temperature was recorded by in-
serting about 3 cm of the thermistor probe of the ther-
mometer (model YB-009) into the rectum. The probe was 
well lubricated (22). For fever induction, turpentine 20% 
at a dose of 20 mL/kg body weight was injected intraperi-
toneally after recording of the initial basal rectal tempera-
ture. The animals were left for one hour. The fever magni-
tude response after one hour of intraperitoneal turpentine 
injection was defined as 100% fever response. The animals 
that recorded 0.8°C raise in rectal temperature were con-
Table 1. Treatment protocol for evaluation of antipyretic activities of 
DCM-MeOH leaf and stem bark extracts Ximenia americana in rats
Group Status Treatment
I Normal control DMSO
II Negative control Turpentine (20%) + DMSO (10%)
III Positive control Turpentine (20%) +100 mg/kg aspirin 
IV Experimental group A Turpentine (20%) +50 mg/kg extract 
V Experimental group B Turpentine (20%) +100 mg/kg extract 
VI Experimental group C Turpentine (20%) +150 mg/kg extract 
DMSO was used as a vehicle.
Phytochemical screening and antipyretic activities of X. americana
Journal of Herbmed Pharmacology, Volume 6, Number 3, July 2017http://www.herbmedpharmacol.com 109
sidered pyretic and were employed in the study.
The rectal temperature was recorded at an hourly interval 
for four hours. The calculation of rectal temperature 
percentage change was done by comparing temperature 
before and after treatment as per the formulae below 
(23,24): 
100B Cn
B
−
×
B: Temperature of the rectum, 1 hour after turpentine 
administration
Cn: Rectal temperature after drug administration.
Qualitative phytochemical screening 
Qualitative phytochemical screening was done on the 
extracts by established methods to find out whether 
selected phytochemicals were present (25,26). The 
secondary metabolites tested were: alkaloids, tannins, 
steroids, saponins, cardiac glycosides, phenolics and 
terpenoids.
Management and statistical analysis of the data
The data on rectal temperature changes were recorded 
and tabulated in a spread sheet. The data was then 
imported to Minitab statistical software version 17 for 
descriptive statistical analysis. The results expressed as 
mean ± standard error of mean for analysis. One-way 
analysis of variance (ANOVA) was performed to compare 
the group means followed by Tukey’s post hoc test for 
pair-wise mean separations and comparisons to obtain 
the specific significant differences among the different 
groups. Un-paired student t test was used to compare 
mean antipyretic activities between leaf and stem bark 
extracts of X. americana.
The statistical significance was considered at P ≤ 0.05. 
The data on the percentage change in rectal temperature 
was presented using graphs.
Results
Antipyretic activity of DCM-MeOH leaf extract of 
Ximenia americana in rats
The DCM-MeOH leaf extracts of X. americana reduced 
rectal temperatures of turpentine-induced pyrexia in rats 
(Table 2; Figure 1). 
The leaf extract of X. americana at three dose levels (50, 
100 and 150 mg/kg body weight), reduced the elevated 
rectal temperatures by 0.98%, 0.93% and 1.27%, respec-
tively, after one hour of the treatment (Figure 1). At all 
dose levels, antipyretic activities of the extract were sig-
nificant in comparison to the normal and negative control 
groups (P < 0.05; Table 2) but there was no significant dif-
ference when compared to the positive group (P ˃ 0.05, 
Table 2).
The DCM-MeOH leaf extract of X. americana at three 
dose levels (50, 100 and 150 mg/kg body weight) caused a 
reduction in elevated rectal temperature by 1.37%, 1.56% 
and 1.76%, respectively after the second hour of the treat-
ment (Figure 1). The antipyretic effectiveness of the ex-
tracts was statistically significant compared to the normal 
and negative control groups (P < 0.05; Table 2), although 
there was no statistical significance when compared to 
positive group (P ˃ 0.05, Table 2).
The leaf extract of X. americana at the three dose levels 
(50, 100 and 150 mg/kg body weight) was found to lower 
the elevated temperature by 0.9%, 1.45% and 2.05%, re-
spectively in the third hour (Figure 1). After three hours, 
the antipyretic activities of the rats treated with 100 and 
150 mg/kg body weight of the extract was comparable to 
the reference group (P ˃ 0.05; Table 2.). At all dose levels 
Table 2. Effects of intraperitoneal administration of DCM-MeOH leaf extract of  Ximenia americana  on turpentine induced pyrexia in rats
Group Treatment
Percent change in rectal temperature (oC) after drug administration
0 h 1 h 2 h 3 h 4 h
Normal control DMSO 100±0.00 100.01 ± 0.02a 100.03 ± 0.07a 100.02 ± 0.01a 100.02 ± 0.01a
Negative control Turpentine  100±0.00 100.02 ± 0.02a 99.995 ± 0.02a 99.947 ± 0.01a 99.900 ± 0.02a
Positive control Turpentine + aspirin (100 mg/kg b.w) 100±0.00 99.089 ± 0.14b 98.610 ± 0.19b 98.373 ± 0.18cd 98.431 ± 0.19bc
DCM: methanolic
Leaf extract
Turpentine + 50 mg/kg 100±0.00 99.018 ± 0.12b 98.626 ± 0.09b 99.098 ± 0.09b 99.554 ± 0.12a
Turpentine + 100 mg/kg 100±0.00 99.071 ± 0.04b 98.544 ± 0.06b 98.549 ± 0.06c 98.808 ± 0.07b
Turpentine + 150 mg/kg 100±0.00 98.734 ± 0.23b 98.239 ± 0.18b 97.950 ± 0.18d 97.892 ± 0.20c
Values are expressed as mean ± SEM for five animals per group. Statistical comparison were made within a column and values with the same superscript 
are not significantly different by one-way ANOVA followed by Tukey’s post hoc test (P  ˃  0.05). Turpentine = 20%; DMSO = 10%;
Figure 1. The change in percentage of rectal temperature caused by 
DCM-MeOH leaf extract of Ximenia americana on turpentine-induced 
pyretic rats
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of the extract, the antipyretic activities were significant in 
comparison to the normal group and the negative group 
(P < 0.05; Table 2).
The three dose levels of the leaf extract (50, 100 and 150 
mg/kg body weight) were found to reduce pyrexia by 
0.45%, 1.19% and 2.11%, respectively after the fourth 
hour (Figure 1). With the aspirin as standard drug, the 
antipyretic activity of the extract was comparable to the 
positive control at the dosages of 100 and 150 mg/kg body 
weight (P ˃ 0.05; Table 2). There was significance in com-
parison to the negative group and normal group (P < 0.05; 
Table 2.). The dose level of 50 mg/kg body showed no sig-
nificant difference from the negative group and the nor-
mal group (P ˃ 0.05; Table 2).
Antipyretic activity of DCM-MeOH stem bark extract of 
Ximenia americana in rats
The DCM-MeOH stem bark extract of X. americana 
showed similar antipyretic activities (Table 3; Figure 2). 
The dichloromethane-MeOH stem bark extract of X. 
americana at three dose levels (50, 100 and 150 mg/kg 
body weight) decreased the elevated rectal temperature by 
0.91%, 0.71% and 0.88%, respectively, after one hour of 
the treatment while aspirin reduced rectal temperature by 
0.74% (Figure 2). At the three dose levels, the activity of 
the extracts was similar to that of aspirin (P ˃ 0.05; Table 
3). At the dose of 100 mg/kg body weight, the activity was 
not significantly different from the normal control group 
(P ˃ 0.05; Table 3). This was as opposed to the dose levels 
of 50 and 150 mg/kg body weight of the extract that was 
significantly different from negative group and the normal 
group (P < 0.05; Table 3).
The dichloromethane-MeOH stem bark extract of X. 
americana at the dose levels of 50, 100 and 150 mg/kg body 
weight decreased the rats’ elevated rectal temperature by 
1.49%, 1.54% and 1.87%, respectively after the second 
hour of the treatment in a dose dependent manner (Figure 
2). These effects were similar to that of aspirin (P ˃ 0.05; 
Table 3).
Ximenia americana stem bark extract at the three dosages 
(50, 100 and 150) in mg/kg body weight, was found to 
reduce the elevated rectal temperature by 1.44%, 1.50% 
and 2.13% respectively in the third hour (Figure 2). The 
antipyretic activities at the three dose levels were not 
Table 3. Effects of intraperitoneal administration of DCM-MeOH stem bark extracts of Ximenia americana  on turpentine-induced pyrexia in rats
Group Treatment
Percent change in rectal temperature (oC) after drug administration
0 h 1 h 2 h 3 h 4 h
Normal control DMSO 100±0.00 99.973 ± 0.09ab 99.995 ± 0.01a 100.02 ± 0.09a 100.01 ± 0.09a
Negative control Turpentine + DMSO 100±0.00 100.77 ± 0.09a 100.82 ± 0.06a 100.64 ± 0.11a 100.48 ± 0.13a
Positive control Turpentine + DMSO + aspirin 100±0.00 99.261 ± 0.08bc 98.865 ± 0.09b 98.329 ± 0.16b 98.575 ± 0.09b
DCM: Methanolic
stem bark extracts
Turpentine + 50 mg/kg 100±0.00 99.088 ± 0.39c 98.510± 0.47b 98.562 ± 0.45b 98.721 ± 0.49b
Turpentine + 100 mg/kg 100±0.00 99.288 ± 0.09bc 98.459 ± 0.12b 98.502 ± 0.14b 98.723 ± 0.09b
Turpentine + 150 mg/kg 100±0.00 99.118 ± 0.15c 98.131 ± 0.08b 97.869 ± 0.19b 97.984 ± 0.19b
Values are expressed as Mean ± SEM for five animals per group. Statistical comparison were made within a column and values with the same superscript 
are not significantly different by one-way ANOVA followed by Tukey’s post hoc test (P  ˃  0.05). Turpentine = 20%; DMSO = 10%; Aspirin = 100 mg/kg. 
significant in comparison to positive group (P ˃ 0.05; 
Table 3).
All the three dose levels (50, 100 and 150 mg/kg body 
weight), were found to reduce fever by 1.28%, 1.28% 
and 2.02%, respectively after the fourth hour (Figure 2). 
The antipyretic activities had no statistically significant 
difference from the positive group (P ˃ 0.05; Table 3).
Comparison between the antipyretic activities of leaf and 
stem bark extract of Ximenia americana
In comparison, there was no significant difference in the 
antipyretic activities at the three dose levels (50, 100 and 
150 mg/kg body weight), at the various test hour period 
of leaf and stem bark extract of X. americana (Figure 
3). During the 4 hours of the test period, the level of 
significance was as follows: at the dosage of 50 mg/kg body 
weight (P = 0.872, 0.821, 0.307 and 0.176 respectively), at 
100 mg/kg body weight (P = 0.084, 0.549, 0.769 and 0.501 
respectively) and at 150 mg/kg body weight (P = 0.205, 
0.608, 0.768 and 0.747 respectively).
Qualitative phytochemical screening
The qualitative phytochemical screening of DCM-MeOH 
leaf and stem bark extracts of X. americana showed the 
presence of alkaloids, cardiac glycosides, flavonoids, 
phenolics, saponins and terpenoids. However, alkaloids 
Figure 2. The change in percentage of rectal temperature caused by 
DCM-MeOH stem bark extract of Ximenia americana on turpentine-
induced pyretic rats.
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and terpenoids were absent in the leaf extract of the X. 
americana while the steroids were absent in both leaf and 
stem bark extracts (Table 4).
Discussion
The present study was designed to evaluate the antipyretic 
activities of DCM-MeOH leaf and stem bark extracts of X. 
americana in rat models.
Pyrexia in rats was used to evaluate the antipyretic activity 
of steam distilled turpentine. Examples of other exogenous 
pyrogens which are used in fever induction in laboratory 
animals are: LPS, brewer’s yeast, polyinosinic polycytidylic 
acid (poly I: C) and muramyl dipeptide (27,28).
Turpentine is injected intraperitoneally into the laboratory 
animals to induce fever. The turpentine-induced fever is 
through increase in prostaglandins synthesis (6). Different 
phytochemicals found in X. americana reduce fever by 
inhibition of these prostaglandins. Turpentine-induced 
fever is tolerated by the animals better than that induced 
by other exogenous pyrogens (7) and it is for this reason it 
was chosen for this study. 
As shown in Tables 2 and 3, there was significant 
antipyretic activity in pyretic rats that was associated 
with administration of DCM-MeOH leaf and stem bark 
extracts of X. americana. The findings were consistent 
Figure 3. The percentage change comparison of rectal temperature caused by DCM-MeOH leaf and stem bark extracts of Ximenia americana on 
turpentine-induced pyrexia in rats.
Table 4. Qualitative phytochemical composition of DCM-MeOH leaf 
and stem bark extracts of Ximenia americana
Phytochemicals X. americana leaf extract
X. americana stem bark 
extract
Alkaloids - +
Flavanoids (+) (+)
Steroids - -  
Saponins  (+) (+)
Cardiac glycosides + +
Phenolics (+) (+)
Terpernoids - +
Present phytochemical is denoted by (+) sign, absent phytochemical 
are denoted by (-) sign while + (trace) denotes slightly present 
phytochemical.
with other studies performed on some other herbal 
extracts in experimental animals. The aqueous stem 
bark extract of X. americana and its fractions showed 
the antipyretic properties (29). The study performed on 
Solanum incanum roots extract confirmed that there was 
antipyretic effect associated with the extract on pyrexia 
induced with lipopolysaccharide in male Wistar rats (30). 
Nonsteroidal anti-inflammatory drugs inhibit COX-2 
expression and thus inhibiting PGE2 biosynthesis leading 
to the reduction in elevated body temperature (31). The 
antipyretic activity of many antipyretic drugs is achieved 
through inhibition of COX-2 and the reduction of PGE2 
levels within the hypothalamus (32). Inhibitors of COX-2 
are potent antipyretics and inhibit the transformation of 
arachidonic acid to PGE2 (33). It is against this background 
that it was believed the extracts from X. americana used in 
this study conferred the antipyretic activities by inhibiting 
COX-2 that lead to reduced PGE2 concentration.
The dose levels of 50, 100 and 150 mg/kg body weight 
were used in this study for the evaluation of antipyretic 
activity of X. americana in turpentine-induced pyrexia in 
rats. Similar dose levels were used to evaluate antipyretic 
activity of organic extracts of Carissa edulis in rats (34). In 
addition, the same dose levels were used in evaluating the 
antipyretic effect of Pseudocedrela kotschyi ethanolic leaf 
extract in rats (35). 
Dose dependent antipyretic activities were observed in the 
DCM-MeOH leaf and stem bark extracts of X. americana. 
The dose of 150 mg/kg produced the highest antipyretic 
activity (Tables 2 and 3). These dose dependent results 
were similar to the work performed on methanol extracts 
of Costus speciosus which had dose dependent antipyretic 
activities in the laboratory animals (36).
The antipyretic activities of DCM-MeOH leaf and stem 
bark extracts of X. americana were most efficient at 150 
mg/kg dose level and least at 50mg/kg dose level (Tables 
2 and 3). 
Aspirin, the standard drug, exhibited optimum antipyretic 
effect during the third hour (Tables 2 and 3). Its activity 
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declined after the third hour which might be attributed to 
its metabolism and excretion. The maximum antipyretic 
effect of the X. americana DCM-MeOH leaf and stem 
bark extracts was observed in the third hour which may 
be attributed to the transport of the bioactive molecules 
across the plasma membrane by passive diffusion from 
peritoneal cavity (37). There was better antipyretic activity 
at the dose level of 150 mg/kg body weight for both 
extracts of X. americana than that of aspirin (Tables 2 and 
3). These findings indicated that probably there is a better 
inhibition of prostaglandin synthesis by the extracts than 
by the reference drug (aspirin).
The presence of several phytochemical constituents in the 
DCM-MeOH leaf and stem bark extracts of X. americana 
might be attributed to the extracts’ antipyretic activities. 
Qualitative phytochemical screening confirmed the 
presence of various phytochemicals such as: alkaloids, 
flavonoids, saponins, terpenoids, cardiac glycosides and 
phenolics, in the extracts. Several of these phytochemicals 
have been shown to exhibit antipyretic effects in the 
experimental animals (38). Alkaloids have been reported 
to inhibit prostaglandin synthesis (39). The antipyretic 
effect observed by the DCM-MeOH leaf and stem bark 
extracts was believed to be due to the presence of the 
several phytochemicals.
Conclusion
In conclusion, the present study confirms the antipyretic 
potential of the leaf and stem bark DCM-MeOH extracts 
of X. americana in experimental animals. The significant 
reduction in rectal temperature which was comparable to 
the reference drug, showed that these extracts are endowed 
with significant antipyretic activities. Therefore, the 
DCM-MeOH leaf and stem bark extracts of X. americana 
might prove useful in managing fever and thus serve as an 
alternative treatment bioresource, which is more effective 
than the conventional synthetic drugs.
The present study showed that DCM-MeOH leaf and 
stem bark extracts of X. americana contain a class of 
phytochemicals attributable to antipyretic properties. 
Therefore, the study scientifically confirms and supports 
the use of X. americana in traditional management of 
fever.
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